BioCentury
ARTICLE | Management Tracks

Frates joins ALS company Amylyx; plus Artios, Valneva, Viravaxx

January 15, 2021 3:22 AM UTC

After two decades at Alkermes plc (NASDAQ:ALKS), James Frates will join neurodegenerative diseases company Amylyx Pharmaceuticals Inc. as CFO on Jan. 25. Frates said he felt a “calling” to do more to combat amyotrophic lateral sclerosis after his cousin Pete Frates was diagnsoed with ALS in 2012. Pete Frates, who lost a seven-year battle with the disease in 2019, helped raise millions of dollars to fight the disease via the Ice Bucket Challenge. Alkermes promoted SVP and Chief Accounting Officer Iain Brown to succeed Frates.

U.K.-based DNA damage repair company Artios Pharma Ltd. hired Abid Ansari as CFO. The former CFO of Precision BioSciences (NASDAQ: DTIL) will be based in the U.S...